Nowotwory Journal of Oncology

ISSN 0029-540x · Via Medica · Poland · active 1933–2026

Metrics

Best Scimago quartile (2025)
Q3
Cites per paper (2y)
0.8
SJR
0.37
h-index
13

“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric (how the two differ). Citation rates differ enormously between fields, so compare within a discipline. What the other figures mean: journal quartile, SJR, h-index and article processing charge.

Data as of 15 November 2026 (venue index build).

Scimago Journal Rank 2025

In the Scimago Journal Rank 2025 edition, Nowotwory Journal of Oncology is Q3 in 1 of its 2 subject categories and Q4 in the other 1. Its best category quartile is Q3.

Scimago 2025 quartile and rank of Nowotwory Journal of Oncology in each subject category
Subject categoryQuartileRank in category
OncologyQ3#305 of 426
Cancer ResearchQ4#196 of 235
Cites per document (2 years, Scopus)
1.00
Documents indexed in 2025 (Scopus)
56

The quartile is the one Scimago prints for each category. Rank is the journal's position by SJR among the journals Scimago lists in that category (#1 is the highest); “—” means we hold no rank consistent with that quartile. The document count is what Scopus indexed that year, which can be lower than a journal's full output. Source: SCImago Journal Rank 2025 edition, from Scopus data (scimagojr.com, CC BY-NC).

Nowotwory Journal of Oncology is Q3 in 1 of its 2 Scimago subject categories (2025 edition; best category Oncology: Q3, #305 of 426), with SJR 0.37 (Scimago) and an h-index of 13 (OpenAlex). Listed in DOAJ, Scopus, PubMed.

Is this the right journal for your paper?

The AI Journal Finder ranks the best-matched journals for your paper’s topic — with tier, open access, citation rate and predatory flags. Free to start.

Try the Journal Finder →

Responding time

Submission to publication
~11 wk
DOAJ self-reported

Turnaround figures are indicative, not a guarantee: DOAJ values are self-reported by the journal (average weeks, submission to publication); library estimates are medians of the received/accepted dates printed in papers we hold. Editorial times vary by article type and season — confirm on the journal’s own site.

Indexing & access

Indexed in
DOAJScopusPubMed
Access status:
gold. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.

Official journal site →

Scope

breastcancertreatmentmedicinephilosophyadvancedradiotherapytechniquesradiationlesionscarcinomaspathology

Frequently asked

Is Nowotwory Journal of Oncology a predatory journal?

Our screening does not flag Nowotwory Journal of Oncology. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in DOAJ, Scopus, PubMed, which is a positive signal.

Is Nowotwory Journal of Oncology indexed in Scopus or Web of Science?

Per our venue index, Nowotwory Journal of Oncology appears in: DOAJ, Scopus, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.

What is the impact factor of Nowotwory Journal of Oncology?

Papers in Nowotwory Journal of Oncology are cited about 0.8 times each within two years of publication, and Scimago places it in Q3, with an h-index of 13. Those are the open equivalents: the Clarivate Journal Impact Factor is a proprietary metric we neither compute nor license, so we show the two-year citation rate and Scimago quartile instead — they answer the same question of how heavily the journal is cited. A citation rate is a property of a field as much as of a journal.

What Scimago quartile is Nowotwory Journal of Oncology (Q1, Q2, Q3, or Q4)?

In the Scimago Journal Rank 2025 edition, Nowotwory Journal of Oncology is Q3 in 1 of its 2 subject categories and Q4 in the other 1. By category: Oncology: Q3, #305 of 426; Cancer Research: Q4, #196 of 235. Its best category quartile is Q3. Quartiles split the journals in a subject category into four equal groups by SJR, so Q1 is the most-cited quarter and Q4 the least; Nowotwory Journal of Oncology is cited about 0.8 times per paper over two years, with an h-index of 13.

What is the Web of Science (JCR) quartile of Nowotwory Journal of Oncology?

The Web of Science quartile comes from Clarivate's Journal Citation Reports (JCR), a proprietary product we neither license nor compute — so we cannot state a JCR quartile for Nowotwory Journal of Oncology. The open equivalent is its best Scimago quartile, Q3 in Oncology, derived from Scopus citation data. Because JCR ranks against Web of Science and Scimago against Scopus, the two can differ, so check Clarivate's site directly if you need the JCR quartile specifically.

Is Nowotwory Journal of Oncology open access?

Our index records its access status as "gold". Where this is derived from publisher-level signals rather than works-level data it is a heuristic, so confirm on the journal's own site — particularly if an article processing charge matters to you.

How long does Nowotwory Journal of Oncology take to publish a paper?

Submission to publication for Nowotwory Journal of Oncology takes about ~11 wk — DOAJ self-reported. Treat it as indicative rather than a guarantee: editorial times vary by article type, reviewer availability and season, and a self-reported figure is the journal's own. We do not hold a peer-review acceptance rate for Nowotwory Journal of Oncology.

Ready to submit? Tools for your next paper

How Pre-Check worksHow AI Review works

Compare the category — Honest roundups of the AI research tools, ours listed alongside the alternatives.

Similar venues

Compare it with its peers: Ranked Oncology journals — ranked by Scimago quartile and cites per paper, predatory venues excluded.

Command palette

Jump anywhere, run any action.